NIC researchers develop new Phase 0 cancer trial; Obama plans longitudinal EMR for veterans;

> We know that drugmakers are a bit leery of comparative-effectiveness research--at least of the way that research could be put into practice. So, just how might the government use data from head-to-head treatment studies? FiercePharma

> Researchers at the National Cancer Institute have developed a new type of cancer trial that they say may speed up discovery of new drugs. The Phase 0 trial involves giving small doses of a drug to a few patients for a short period of time. FierceBiotech

> The Obama Administration announced last week that it will be rolling out an EMR for veterans that will contain all of their clinical and administrative information from the moment of enlistment to their death. In making this promise, the administration is taking on an issue--interconnection between different types of data and different providers--that has dragged on for several years without any apparent resolution as of yet. FierceHealthIT

And Finally... Payback can be...well, you know. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.